OBIZUR (Baxter Healthcare Corporation)
Welcome to the PulseAid listing for the OBIZUR drug offered from Baxter Healthcare Corporation. This pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | Baxter Healthcare Corporation |
| NON-PROPRIETARY NAME: | ANTIHEMOPHILIC FACTOR PORCINE, B-DOMAIN TRUNCATED RECOMBINANT |
| SUBSTANCE NAME: | |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2014-10-23 |
| END MARKETING DATE: | 0000-00-00 |
OBIZUR PLASMA DERIVATIVE Details:
| Item Description | OBIZUR from Baxter Healthcare Corporation |
| LABELER NAME: | Baxter Healthcare Corporation |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2014-10-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0944-5001_a69ccbb3-7648-4978-8c6d-7ca6b95a9b01 |
| PRODUCT NDC: | 0944-5001 |
| APPLICATION NUMBER: | BLA125512 |